Monsanto (MON) Merger Spread Widens as Doubts Grow
- Wall St. lower as earnings from some big names disappoint
- General Motors (GM) Tops Q3 EPS by 28c
- Procter & Gamble (PG) Tops Q1 EPS by 5c
- DuPont (DD) Tops Q3 EPS by 14c; Boosts FY16 EPS Outlook; Says Continuing to Work with Regulators
- Pre-Open Stock Movers 10/25: (SAEX) (CWEI) (SWFT) Higher; (DPRX) (CRBP) (UA) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
The merger arb spread on yesterday's massive $66 billion takeover of Monsanto (NYSE: MON) by Bayer is heading in the wrong direction, according to StreetInsider's Merger Arbitrage tracker. Yesterday, Monsanto agreed to be taken over for $128 per share in cash but today the stock is trading down to $104.56. With the drop, the spread has widened by 2.5% to 22.4%. As a comparison, the spread on the deals that are expected to close would only be a few percentage points. Meanwhile, the spread on Anthem (NYSE: ANTM)/Cigna (NYSE: CI), a deal that is expected to fall apart, is 30.8%.
If the deal goes through investors can make a return of 22.4% for doing no work. However "if" is the key word. The large spread is a major red-flag.
With the deal not expected to close until the end of 2017 there is a lot of time for things to go wrong. Politicians are already clamoring against the deal and antitrust attorneys are readying their pencils.
Some arbs only see a 50-50 chance of the deal closing.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- T-Mobile seen as top target following AT&T-Time Warner deal
- Pluristem Therapeutics (PSTI) Enters $30M Equity Investment Agreement with China's Innovative Medical
- Access National (ANCX) to Acquire Middleburg Financial (MBRG) in ~$233M Deal
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Trader Talk
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!